Title |
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
|
---|---|
Published by |
John Wiley & Sons, Ltd, September 2012
|
DOI | 10.1002/14651858.cd007498.pub2 |
Pubmed ID | |
Authors |
Schuetz, Philipp, Müller, Beat, Christ-Crain, Mirjam, Stolz, Daiana, Tamm, Michael, Bouadma, Lila, Luyt, Charles E, Wolff, Michel, Chastre, Jean, Tubach, Florence, Kristoffersen, Kristina B, Burkhardt, Olaf, Welte, Tobias, Schroeder, Stefan, Nobre, Vandack, Wei, Long, Bhatnagar, Neera, Bucher, Heiner C, Briel, Matthias |
Abstract |
Acute respiratory infections (ARIs) comprise a large and heterogeneous group of infections including bacterial, viral and other aetiologies. In recent years, procalcitonin - the prohormone of calcitonin - has emerged as a promising marker for the diagnosis of bacterial infections and for improving decisions about antibiotic therapy. Several randomised controlled trials (RCTs) have demonstrated the feasibility of using procalcitonin for starting and stopping antibiotics in different patient populations with acute respiratory infections and different settings ranging from primary care to emergency departments (EDs), hospital wards and intensive care units (ICUs). |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 23 | 21% |
Spain | 8 | 7% |
United States | 7 | 7% |
Mexico | 3 | 3% |
France | 3 | 3% |
Canada | 2 | 2% |
Venezuela, Bolivarian Republic of | 2 | 2% |
India | 2 | 2% |
Italy | 1 | <1% |
Other | 6 | 6% |
Unknown | 50 | 47% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 70 | 65% |
Practitioners (doctors, other healthcare professionals) | 25 | 23% |
Scientists | 8 | 7% |
Science communicators (journalists, bloggers, editors) | 4 | 4% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 5 | 2% |
United States | 3 | 1% |
Brazil | 3 | 1% |
Switzerland | 1 | <1% |
Turkey | 1 | <1% |
Colombia | 1 | <1% |
Japan | 1 | <1% |
Mexico | 1 | <1% |
Unknown | 268 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 45 | 16% |
Student > Master | 37 | 13% |
Researcher | 34 | 12% |
Student > Ph. D. Student | 31 | 11% |
Student > Bachelor | 24 | 8% |
Other | 74 | 26% |
Unknown | 39 | 14% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 170 | 60% |
Nursing and Health Professions | 12 | 4% |
Immunology and Microbiology | 9 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 9 | 3% |
Agricultural and Biological Sciences | 8 | 3% |
Other | 26 | 9% |
Unknown | 50 | 18% |